Search Results - "VAN DER HEIDEN, P. L. J"

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation by van der Heiden, P. L. J., Arbous, M. S., van Beers, E. J., van den Bergh, W. M., le Cessie, S., Demandt, A. M. P., Eefting, M., Hess, C., Kusadasi, N., Marijt, W. A. F., van Mook, W. N. K. A., Müller, M. C. A., Tuinman, P. R., van Vliet, M., van Westerloo, D. J., Blijlevens, N. M. A.

“…Historically, the mortality of patients admitted to the ICU after allogeneic stem cell transplantation (alloSCT) is high. Advancements in transplantation…”
Get full text

Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning by KALPOE, J. S, VAN DER HEIDEN, P. L. J, VAESSEN, N, CLAAS, E. C. J, BARGE, R. M, KROES, A. C. M

“…Reports on infectious complications following reduced intensity conditioning (RIC) before allogeneic stem cell transplantation (allo-SCT) are equivocal. This…”
Get full text

Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients by VAN DER HEIDEN, P. L. J, KALPOE, J. S, BARGE, R. M, WILLEMZE, R, KROES, A. C. M, SCHIPPERS, E. F

“…The efficacy and safety of oral valganciclovir was compared to ganciclovir i.v. in pre-emptive treatment of cytomegalovirus (CMV) in T-cell-depleted allogeneic…”
Get full text

CMV seronegative donors: Effect on clinical severity of CMV infection and reconstitution of CMV-specific immunity by van der Heiden, P.L.J., van Egmond, H.M., Veld, S.A.J., van de Meent, M., Eefting, M., de Wreede, L.C., Halkes, C.J.M., Falkenburg, J.H.F., Marijt, W.A.F., Jedema, I.

“…Cytomegalovirus (CMV)-specific T-cells are crucial to prevent CMV disease. CMV seropositive recipients transplanted with stem cells from a CMV seronegative…”
Get full text

Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia by van der Heiden, P. L. J., Jedema, I., Willemze, R., Barge, R. M. Y.

“…:  Gemtuzumab ozogamicin (GO) is a recently developed antibody‐targeted chemotherapeutic agent and has been expected to be less toxic than conventional…”
Get full text

Association of intensity of ventilation with 28-day mortality in COVID-19 patients with acute respiratory failure: insights from the PRoVENT-COVID study by Schuijt, Michiel T. U., Schultz, Marcus J., Paulus, Frederique, Serpa Neto, Ary, van Akkeren, J. P., Algera, A. G., Algoe, C. K., van Amstel, R. B., Baur, O. L., van de Berg, P., Bergmans, D. C. J. J., van den Bersselaar, D. I., Bertens, F. A., Bindels, A. J. G. H., de Boer, M. M., Boer, S.den, Boers, L. S., Bogerd, M., Bos, L. D. J., Botta, M., Breel, J. S., de Bruin, H., de Bruin, S., Bruna, C. L., Buiteman-Kruizinga, L. A., Cremer, O., Determann, R. M., Dieperink, W., Dongelmans, D. A., Franke, H. S., Aldridge, M. S. Galek, de Graaff, M. J., Hagens, L. A., Haringman, J. J., Heijnen, N. F. L., Hiel, S., van der Heide, S. T., van der Heiden, P. L. J., Hoeijmakers, L. L., Hol, L., Hollmann, M. W., Hoogendoorn, M. E., Horn, J., van der Horst, R., Ie, E. L. K., Ivanov, D., Juffermans, N. P., Kho, E., de Klerk, E. S., Koopman, A. W. M., Koopmans, M., Kucukcelebi, S., Kuiper, M. A., de Lange, D. W., van Meenen, D. M., Martin-Loeches, Ignacio, Mazzinari, Guido, van Mourik, N., Nijbroek, S. G., Onrust, M., Oostdijk, E. A. N., Paulus, F., Pennartz, C. J., Pillay, J., Pisani, L., Purmer, I. M., Rettig, T. C. D., Roozeman, J. P., Schuijt, M. T. U., Schultz, M. J., Neto, A. Serpa, Sleeswijk, M. E., Smit, M. R., Spronk, P. E., Stilma, W., Strang, A. C., Tsonas, A. M., Tuinman, P. R., Valk, C. M. A., Veen, F. L., Vlaar, A. P. J., Veldhuis, L. I., van Velzen, P., van der Ven, W. H., van Vliet, P., van der Voort, P., van der Wier, H. H., van Welie, L., Wesselink, H. J. F. T., van Wijk, B., Winters, T., Wong, W. Y., van Zanten, A. R. H.

“…Abstract Background The intensity of ventilation, reflected by driving pressure (ΔP) and mechanical power (MP), has an association with outcome in invasively…”
Get full text

Association between early cumulative fluid balance and successful liberation from invasive ventilation in COVID-19 ARDS patients - insights from the PRoVENT-COVID study: a national, multicenter, observational cohort analysis by Ahuja, Sanchit, de Grooth, Harm-Jan, Paulus, Frederique, van der Ven, Fleur L, Serpa Neto, Ary, Schultz, Marcus J, Tuinman, Pieter R

“…Increasing evidence indicates the potential benefits of restricted fluid management in critically ill patients. Evidence lacks on the optimal fluid management…”
Get full text

Prognostication using SpO2/FiO2 in invasively ventilated ICU patients with ARDS due to COVID-19 – Insights from the PRoVENT-COVID study by Roozeman, Jan-Paul, Mazzinari, Guido, Serpa Neto, Ary, Hollmann, Markus W., Paulus, Frederique, Schultz, Marcus J., Pisani, Luigi, Algera, A.G., Boers, L.S., Bos, L.D.J., Botta, M., Dongelmans, D.A., Hollmann, M.W., Horn, J., Paulus, F., Pillay, J., Schultz, M.J., Neto, A. Serpa, Tsonas, A.M., Vlaar, A.P.J., Ahuja, S., van Akkeren, J.P., Algoe, C.K., van Amstel, R.B., Artigas, A., Baur, O.L., van de Berg, P., van den Berg, A.E., Bergmans, D.C.J.J., van den Bersselaar, D.I., Bertens, F.A., Bindels, A.J.G.H., de Boer, M.M., den Boer, S., Bogerd, M., Breel, J.S., de Bruin, H., de Bruin, S., Bruna, C.L., Buiteman-Kruizinga, L.A., Cremer, O.L., Determann, R.M., Dieperink, W., Franke, H.S., Galek-Aldridge, M.S., de Graaff, M.J., Hagens, L.A., Haringman, J.J., van der Heide, S.T., van der Heiden, P.L.J., Heijnen, N.F.L., Hiel, S.J.P., Hoeijmakers, L.L., Hol, L., Hoogendoorn, M.E., van der Horst, R., Ie, E.L.K., Ivanov, D., Juffermans, N.P., Kho, E., de Klerk, E.S., Gemert, A.W.M.M. Koopman-van, Koopmans, M., Kucukcelebi, S., Kuiper, M.A., de Lange, D.W., van Mourik, N., Nijbroek, S.G., Onrust, M., Oostdijk, E.A.N., Pennartz, C.J., Pisani, L., Purmer, I.M., Rettig, T.C.D., Roozeman, J.P., Schuijt, M.T.U., Sleeswijk, M.E., Smit, M.R., Spronk, P.E., Stilma, W., Strang, A.C., Tuinman, P.R., Valk, C.M.A., Veen-Schra, F.L., Veldhuis, L.I., van Velzen, P., van der Ven, W.H., van Vliet, P., van der Voort, P.H.J., van Welie, L., Wesselink, H.J.F.T., van der Wier-Lubbers, H.H., van Wijk, B., Winters, T., Wong, W.Y., van Zanten, A.R.H.

“…The SpO2/FiO2 is a useful oxygenation parameter with prognostic capacity in patients with ARDS. We investigated the prognostic capacity of SpO2/FiO2 for…”
Get full text